Loading
What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/buck-institute.md — the filesystem corpus, unchanged. Not an edit.
11.2 kB
Revision 1
Revision 2
lines 7–14 → 7–136 unchanged lines not shown
categories: ["organizations", "longevity"]categories: ["organizations", "longevity"]tags: ["aging", "biogerontology", "research institutes", "senescence", "training", "nonprofit"]tags: ["aging", "biogerontology", "research institutes", "senescence", "training", "nonprofit"]summary: "An independent research institute in Novato, California, opened in 1999 as the first in the world dedicated solely to the biology of aging."summary: "An independent research institute in Novato, California, opened in 1999 as the first in the world dedicated solely to the biology of aging."updated: "2026-07-27"updated: "2026-08-23"issues: ["Scale figures for laboratory count and annual expenditure carry no source."]------ ```infobox```infoboxlines 32–44 → 31–4317 unchanged lines not shown
The institute's organizing claim is the geroscience premise: that the major chronic diseases of later life share upstream biological drivers, and that intervening on those drivers would do more good than treating each disease separately. Its research is organized around aging mechanisms rather than around organ systems or diseases, which is unusual for a biomedical institute and was more unusual still when it opened.The institute's organizing claim is the geroscience premise: that the major chronic diseases of later life share upstream biological drivers, and that intervening on those drivers would do more good than treating each disease separately. Its research is organized around aging mechanisms rather than around organ systems or diseases, which is unusual for a biomedical institute and was more unusual still when it opened. It runs roughly two dozen laboratories, a graduate programme, and a translational arm intended to move findings toward companies. Its scale is modest — annual expenditure in the tens of millions of dollars — relative to [[calico]] or [[altos-labs]], and its output per dollar has been correspondingly high.The institute lists 26 faculty and research professors,[^buck2026] alongside a graduate programme and a translational arm intended to move findings toward companies. Its scale is modest — expenses of roughly $63 million in the fiscal year ending June 2025, against revenue of $57 million, per its federal filings[^propublica2025] — relative to [[calico]] or [[altos-labs]], and its output per dollar has been correspondingly high. ## History## History The institute exists because of a lawsuit. Leonard and Beryl Buck left a charitable trust for use in Marin County, California; the trust's assets grew far beyond expectation after the value of its holdings rose, and the resulting litigation in the 1980s over whether the money had to be spent within one wealthy county produced a settlement that funded several new institutions, among them a research centre on aging.The institute exists because of a lawsuit. Leonard and Beryl Buck left a charitable trust for use in Marin County, California; the trust's assets grew far beyond expectation after the value of its holdings rose, and the resulting litigation in the 1980s over whether the money had to be spent within one wealthy county produced a settlement that funded several new institutions, among them a research centre on aging. Construction on a campus designed by I. M. Pei began in the 1990s and the institute opened in 1999. Dale Bredesen was its founding president. Brian Kennedy, a yeast geneticist known for work on the genetics of lifespan, led it during the first half of the 2010s, and Eric Verdin, an immunologist and metabolism researcher, has been president since 2016.Construction on a campus designed by I. M. Pei began in the 1990s and the institute opened in 1999. Dale Bredesen was its founding president. Brian Kennedy, a yeast geneticist known for work on the genetics of lifespan, led it during the first half of the 2010s, and Eric Verdin, an immunologist and metabolism researcher, has been president and chief executive since late 2016, with the autophagy researcher Malene Hansen serving as chief scientific officer.[^buck2026] ```timeline```timeline[[lines 76–82 → 75–8131 unchanged lines not shown
## Funding## Funding The institute is funded by a combination of the original endowment, competitive federal grants — principally from the National Institute on Aging — philanthropy, and industry collaboration. It is not a university and grants no undergraduate degrees, but it operates a doctoral programme in the biology of aging in partnership with the University of Southern California, one of very few graduate programmes anywhere organized around the subject.The institute is funded by a combination of the original endowment, competitive federal grants — principally from the National Institute on Aging — philanthropy, and industry collaboration; its filings for the fiscal year ending June 2025 report contributions and grants as the large majority of revenue.[^propublica2025] It is not a university and grants no undergraduate degrees, but it operates a doctoral programme in the biology of aging in partnership with the University of Southern California, one of very few graduate programmes anywhere organized around the subject. That programme is the institute's second major contribution. Aging biology had no training pipeline of its own until relatively recently, and researchers entered it laterally from cancer biology, genetics or metabolism. A dedicated programme produces people who frame their questions in the field's own terms from the start.That programme is the institute's second major contribution. Aging biology had no training pipeline of its own until relatively recently, and researchers entered it laterally from cancer biology, genetics or metabolism. A dedicated programme produces people who frame their questions in the field's own terms from the start. lines 110–113 → 109–11427 unchanged lines not shown
[^coppe2008]: `paper` Coppé, J.-P., Patil, C.K., Rodier, F. et al. "Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor." *PLoS Biology*, 2008. {The secretory phenotype was characterised in cultured cells; its role in aged tissue was inferred from later work.}[^coppe2008]: `paper` Coppé, J.-P., Patil, C.K., Rodier, F. et al. "Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor." *PLoS Biology*, 2008. {The secretory phenotype was characterised in cultured cells; its role in aged tissue was inferred from later work.}[^baker2011]: `paper` Baker, D.J. et al. "Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders." *Nature*, 2011. {The mice were a progeroid strain carrying a transgene that let p16-positive cells be killed on demand, not normally aged animals.}[^baker2011]: `paper` Baker, D.J. et al. "Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders." *Nature*, 2011. {The mice were a progeroid strain carrying a transgene that let p16-positive cells be killed on demand, not normally aged animals.}[^campisi2013]: `paper` Campisi, J. "Aging, Cellular Senescence, and Cancer." *Annual Review of Physiology*, 2013.[^campisi2013]: `paper` Campisi, J. "Aging, Cellular Senescence, and Cancer." *Annual Review of Physiology*, 2013.[^buck2026]: `statement` Buck Institute for Research on Aging. "Leadership" and "Faculty." buckinstitute.org, accessed August 2026. {The institute's own pages; they record its stated faculty count and officer roster, not an independent census.}[^propublica2025]: `report` ProPublica Nonprofit Explorer. "Buck Institute for Research on Aging," IRS Form 990 filings through fiscal year ending June 2025. {The figures are the institute's own filings to the IRS, republished by ProPublica; the fiscal 2025 return reports $57.2 million in revenue and $62.9 million in expenses.} removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
108 lines are the same in both revisions, and 81 of them are not shown. Neither revision here is necessarily the current article — read Buck Institute for Research on Aging for the text this wiki stands behind today.